Research suggests that Boswellia (frankincense) has meaningful anti-inflammatory properties, primarily attributed to boswellic acids — especially acetyl-11-keto-β-boswellic acid (AKBA) — which appear to work by inhibiting key inflammatory pathways including 5-lipoxygenase, leukotriene synthesis, cyclooxygenase enzymes, and prostaglandin E2 production through multiple molecular targets. The available evidence base consists largely of in vitro studies, animal models, and narrative or systematic reviews, with some clinical trials supporting effectiveness in conditions such as osteoarthritis, asthma, inflammatory bowel conditions, and psoriasis, though researchers consistently note that more rigorous and large-scale human trials are needed before definitive conclusions can be drawn. Studies indicate that additional bioactive compounds beyond boswellic acids — including cembranoids, diterpenoids like incensole acetate, and triterpene acids such as tirucallic and lupeolic acids — also contribute to the anti-inflammatory effects, suggesting the resin's activity is more complex than early research recognized. A notable limitation flagged across multiple reviews is the poor oral bioavailability of boswellic acids, which raises questions about how well laboratory and animal findings translate to real-world human use, and researchers have identified improved formulation strategies and chemical modification as areas requiring further development.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatm... | Systematic review | 2022 | Supports | 100 |
| Frankincense--therapeutic properties. | Review | 2016 | Supports | 95 |
| Molecular evidences on anti-inflammatory, anticancer, and memory-boosting eff... | Review | 2022 | Supports | 90 |
| Frankincense diterpenes as a bio-source for drug discovery. | Review | 2022 | Supports | 85 |
| Cembranoids from Boswellia species. | Review | 2021 | Supports | 80 |
| Distribution of the anti-inflammatory and anti-depressant compounds: Incensol... | Review | 2019 | Supports | 75 |
| Frankincense ( rǔ xiāng; boswellia species): from the selection of traditiona... | Review | 2013 | Supports | 70 |
| Chemical Constituents and Pharmacological Properties of Frankincense: Implica... | Systematic review | 2024 | Supports | 65 |
| Frankincense: A neuronutrient to approach Parkinson's disease treatment. | Review | 2024 | Supports | 60 |
| Boswellia frereana (frankincense) suppresses cytokine-induced matrix metallop... | Other | 2010 | Supports | 55 |
| Frankincense (Boswellia serrata) Extract Effects on Growth and Biofilm Format... | Other | 2024 | Neutral | 50 |
| Effect of Boswellia species on the metabolic syndrome: A review. | Review | 2020 | Supports | 45 |
| Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory re... | Other | 2014 | Supports | 40 |
| α-Pinene, linalool, and 1-octanol contribute to the topical anti-inflammatory... | Other | 2016 | Supports | 35 |
| Prospects of boswellic acids as potential pharmaceutics. | Review | 2015 | Mixed | 30 |